MOG and ocular melanoma: To minimize potential effects on T cell activation and proliferation (26), GEM (i.p. 60 mg/Kg) was first administered in groups of OM-MOG- and vehicle-treated EAE mice on dpi 6 and 10 close to disease onset (Figure 2A).